Do not receive SYFOVRE if you: have an infection in or around your eye have active swelling in or around your eye that may include pain and redness SYFOVRE can cause serious side effects: Eye infection (endophthalmitis) or separation of layers of the retina (retinal detachment) Call your healthcare provider right away if you have [Read More]
Category: Therapies, Treatments, and Procedures
Susvimo implant for Wet AMD Voluntarily Recalled
BYOOVIZ™ Launches in the U.S.
Biogen Inc. and Samsung Bioepis Co., Ltd. has announced that BYOOVIZ™ (ranibizumab-nuna), a biosimilar of LUCENTIS® (ranibizumab) has been launched in the U.S. and will be commercially available on July 1, 2022. The list price will be $1,130 per injection, which is 40% lower than the current list price of LUCENTIS. The FDA approved BYOOVIZ [Read More]
Does VUITY™ Treat AMD?
A new drug called VUITY™ (pilocarpine hydrochloride ophthalmic solution) has recently gained attention as an eye drop that can improve near (close up) vision in individuals over 40. It does not, however, change the condition of the retina. The drug, made by Allergan, works as advertised, but it should not be expected to treat age-related [Read More]
Long-awaited Faricimab for wet AMD and DME approved
The FDA has approved Genentech’s Vabysmo (first announced here as faricimab), the only injectable eye medicine approved simultaneously in the U.S. for wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Vabysmo will be administered using flexible dosing regimens based on patient need. The medication targets and inhibits two disease pathways by neutralizing angiopoietin-2 [Read More]